Table 5 Co-resistance of carbapenem non-susceptible K. pneumoniae isolates (n = 966) against other antibiotics

Tested against

Included isolates

Non-susceptible isolates, % (95%CI)^b

Included isolates

Non-susceptible isolates, % (95%CI)^b

Ampicillin/ Sulbactam

871

93.0% (90.3, 95.0%)

c

c

Piperacillin/ Tazobactam

950

90.7% (87.4, 93.2%)

c

c

Ceftazidime

954

88.7% (85.8, 91.0%)

c

c

Cefotaxime

908

88.3% (85.0, 91.0%)

c

c

Polymyxin/ Colistin

435

13.3% (9.8, 17.9%)

214

14.0% (8.8, 21.7%)

Tigecycline

865

56.6% (51.0, 62.1%)

709

55.6% (49.1, 61.8%)

Fosfomycin

632

47.0% (40.6, 53.5%)

319

46.7% (36.2, 57.5%)

Gentamicin

960

57.8% (53.0, 62.4%)

c

c

Co-Trimoxazole

961

62.7% (57.6, 67.6%)

c

c

Ciprofloxacin

959

82.0% (78.4, 85.0%)

c

c

Nitrofurantoin

313

82.7% (76.3, 87.7%)

99

72.7% (60.0, 82.6%)